PGD2 potentiated pulmonary eosinophilic inflammation by the activation of chemoattractant receptor homologous molecules expressed in Th2 cells (CRTH2) and accumulation of eosinophil from circulation to the airway, whereas CRTH2 antagonist effectively controlled the airway inflammation [60]. The gene discussed is PTGDR2; the disease is inflammation.